The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Sterol Regulatory Element Binding Protein 2 Activation of NLRP3 Inflammasome in Endothelium Mediates Hemodynamic-Induced Atherosclerosis Susceptibility
Open accessAbstract
Background—: The molecular basis for the focal nature of atherosclerotic lesions is poorly understood. Here, we explored whether disturbed flow patterns activate an innate immune response to form the NLRP3 inflammasome scaffold in vascular endothelial cells via sterol regulatory element binding protein 2 (SREBP2). Methods and Results—: Oscillatory flow activates SREBP2 and induces NLRP3 inflammasome in endothelial cells. The underlying mechanisms involve SREBP2 transactivating NADPH oxidase 2 and NLRP3. Consistently, SREBP2, NADPH oxidase 2, and NLRP3 levels were elevated in atheroprone areas of mouse aortas, suggesting that the SREBP2-activated NLRP3 inflammasome causes functionally disturbed endothelium with increased inflammation. Mimicking the effect of atheroprone flow, endothelial cell–specific overexpression of the activated form of SREBP2 synergized with hyperlipidemia to increase atherosclerosis in the atheroresistant areas of mouse aortas. Conclusions—: Atheroprone flow induces NLRP3 inflammasome in endothelium through SREBP2 activation. This increased innate immunity in endothelium synergizes with hyperlipidemia to cause topographical distribution of atherosclerotic lesions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Xiao et al11 additionally reported that atheroprone flow induces the NLRP3 inflammasome in endothelium through serol regulatory element binding protein 2 activation.”
From Trimethylamine‐N‐Oxide Induces Vascular Inflammation by Activating the NLRP3 Inflammasome Through the SIRT3‐SOD2‐mtROS Signaling Pathway (2017) · cites this paper as [11]
In the citing paper
“This increased innate immunity in endothelium synergizes with hyperlipidemia to cause topographical distribution of atherosclerotic lesions.11”
From Trimethylamine‐N‐Oxide Induces Vascular Inflammation by Activating the NLRP3 Inflammasome Through the SIRT3‐SOD2‐mtROS Signaling Pathway (2017) · cites this paper as [11]
In the citing paper
“Moreover, recent studies have demonstrated that sterol regulatory element binding protein 2 activation of NLRP3 inflammasome in endothelium mediates hemodynamic‐induced AS susceptibility,11”
From Trimethylamine‐N‐Oxide Induces Vascular Inflammation by Activating the NLRP3 Inflammasome Through the SIRT3‐SOD2‐mtROS Signaling Pathway (2017) · cites this paper as [11]
In the citing paper
“These results clearly indicate that the NLRP3 inflammasome plays a key role in the pathogenesis of vascular inflammation, thereby contributing to AS development.”
From Trimethylamine‐N‐Oxide Induces Vascular Inflammation by Activating the NLRP3 Inflammasome Through the SIRT3‐SOD2‐mtROS Signaling Pathway (2017) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026
Thioredoxin-interacting protein links oxidative stress to inflammasome activation
Zhou, R., Tardivel, A., Thorens, B., Choi, I., & Tschopp, J. (2010) · Nature Immunology · doi:10.1038/ni.1831 · Cited by 2,708
Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
Dostert, C., Pétrilli, V., Van Bruggen, R., Steele, C., Mossman, B. T., & Tschopp, J. (2008) · Science · doi:10.1126/science.1156995 · Cited by 2,658
Chiu, J.-J., & Chien, S. (2011) · Physiological Reviews · doi:10.1152/physrev.00047.2009 · Cited by 2,280
Li, Y., Xu, S., Mihaylova, M. M., Zheng, B., Hou, X., Jiang, B., Park, O., Luo, Z., Lefai, É., Shyy, J. Y.-J., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.03.009 · Cited by 1,840
Self-citationMiR-33 Contributes to the Regulation of Cholesterol Homeostasis
Rayner, K. J., Suárez, Y., Dávalos, A., Parathath, S., Fitzgerald, M. L., Tamehiro, N., Fisher, E. A., Moore, K. J., & Fernández-Hernando, C. (2010) · Science · doi:10.1126/science.1189862 · Cited by 1,260
Hemodynamic shear stress and the endothelium in cardiovascular pathophysiology
Davies, P. F. (2008) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio1397 · Cited by 1,216
Rajamäki, K., Lappalainen, J., Öörni, K., Välimäki, E., Matikainen, S., Kovanen, P. T., & Eklund, K. K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011765 · Cited by 1,039
MicroRNA-33 and the SREBP Host Genes Cooperate to Control Cholesterol Homeostasis
Najafi-Shoushtari, S. H., Kristo, F., Li, Y., Shioda, T., Cohen, D. E., Gerszten, R. E., & Näär, A. M. (2010) · Science · doi:10.1126/science.1189123 · Cited by 957 · cited 2×
“In macrophages, the SREBP2-coinduced miR-33a targets ABCA1, which impairs reverse cholesterol transport.(5,6) An antigomir against miR-33 decreases atherosclerosis in LDL receptor–null mice, with a concomitant increase in the level of high-density lipoprotein.”
Background
Cited by
Sorted by citations
Items 201–257 of 257
Xue, S., Wang, J., Zhang, X., Shi, Y., Li, B., Bao, Q., Pang, W., Ai, D., Zhu, Y., & He, J. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.06.050 · Cited by 10
Chen, Y., Boini, K. M., Pitzer, A. L., Zhang, Y., & Li, P. (2014) · The FASEB Journal · doi:10.1096/fasebj.28.1_supplement.851.5 · Cited by 10
12/15-lipoxygenase mediates disturbed flow-induced endothelial dysfunction and atherosclerosis
Chen, J. W., Chen, S., Wu, X. R., Shu, X. Y., Tang, S. Y., Yuan, H., Li, Y. R., Quan, J. W., Feng, S., Zhang, R., et al. (2025) · Molecular Medicine · doi:10.1186/s10020-025-01297-0 · Cited by 11
Self-citationRheumatoid arthritis and cardiovascular diseases: close relatives or friends?
Gordeev, A. V., Olyunin, Y. A., Galushko, E. A., Zotkin, E. G., & Lila, A. M. (2023) · Modern Rheumatology Journal · doi:10.14412/1996-7012-2023-2-16-22 · Cited by 11
SREBPs as the potential target for solving the polypharmacy dilemma
Wang, X., Chen, Y., Meng, H., & Meng, F. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2023.1272540 · Cited by 11
Inflammation and Atherosclerosis
Papadimitraki, E. D., & Boumpas, D. T. (2014) · Springer eBooks · doi:10.1007/978-3-319-08798-6_13 · Cited by 9
He, J., Duan, P., Liu, Y., Feng, T., Wang, S., Lin, X., Xie, J., & Liu, X. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202304439 · Cited by 8
Bacterial metabolites and cardiovascular risk in children with chronic kidney disease
Schlender, J., Behrens, F., McParland, V. J., Müller, D. N., Wilck, N., Bartolomaeus, H., & Holle, J. B. (2021) · Molecular and Cellular Pediatrics · doi:10.1186/s40348-021-00126-8 · Cited by 10
Sprenger, S., Woldemariam, T. Z., Kotchoni, S. O., Elshabrawy, H. A., & Chaturvedi, L. S. (2022) · Journal of Food Biochemistry · doi:10.1111/jfbc.14037 · Cited by 8
Endothelial Metabolic Reprogramming Links Diabetes to Atherosclerosis
Pan, Y., & Si, J. (2026) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s565805 · Cited by 9
Reynolds, C. M., Li, M., Gray, C. L., & Vickers, M. H. (2014) · Growth Factors · doi:10.3109/08977194.2013.870169 · Cited by 7
Chen, Q., Devine, I., Walker, S., Pham, H., Ondrasik, R. M., Patel, H., Chau, W. L., Parker, C. W., Bartol, K. D., Riahi, S., et al. (2016) · American Journal of Biomedical Sciences · doi:10.5099/aj160300208 · Cited by 7
Rasmi, R. R., Kovatich, R., Farley, A., Sakthivel, K. M., Takiar, V., & Sertorio, M. G. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.112044 · Cited by 10
Systems Biology Analysis of Temporal Dynamics That Govern Endothelial Response to Cyclic Stretch
Lai, M. W., Chow, N., Checco, A., Kunar, B., Redmond, D., Rafii, S., & Rabbany, S. Y. (2022) · Biomolecules · doi:10.3390/biom12121837 · Cited by 6
Memetimin, H., Zhu, B., Lee, S., Katz, W. S., Kern, P. A., & Finlin, B. S. (2022) · Scientific Reports · doi:10.1038/s41598-022-26995-1 · Cited by 5
The NLRP3 Inflammasome: A Possible Therapeutic Target for Treatment of Stroke
Ishrat, T., & Nasoohi, S. (2017) · Springer series in translational stroke research · doi:10.1007/978-3-319-66679-2_22 · Cited by 5
Li, Q., Wang, H., Zhang, C., Tong, R., Chen, H., & Qie, R. (2020) · PubMed Central · Cited by 6
Hyperactivation of SREBP induces pannexin-1-dependent lytic cell death
Xiong, Y., Luo, J., Hong, Z.-Y., Zhu, W.-Z., Hu, A., & Song, B.-L. (2024) · Journal of Lipid Research · doi:10.1016/j.jlr.2024.100579 · Cited by 5
Cancro, F. P., Bellino, M., Silverio, A., Maio, M. D., Esposito, L., Palumbo, R., Manna, M., Formisano, C., Ferruzzi, G. J., Vecchione, C., et al. (2024) · Translational Medicine UniSa · doi:10.37825/2239-9747.1058 · Cited by 5
Bibliometric evaluation of publications on inflammasomes in atherosclerosis from 2002 to 2022
Tan, Y. T., Yu, Y., Liu, W., Ma, X., & Shi, D. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1067226 · Cited by 5
Liu, M., Lin, X., & Xiao, L. (2024) · Molecular Medicine Reports · doi:10.3892/mmr.2024.13173 · Cited by 5
Smetanina, M. A., Korolenya, V. A., Kel, A. E., Sevostyanova, K. S., Gavrilov, K. A., Shevela, A. I., & Филипенко, М. Л. (2023) · Epigenomes · doi:10.3390/epigenomes7010008 · Cited by 4
Inflammasomes as Potential Therapeutic Targets in Atherosclerotic Cardiovascular Disease
Wang, P., Ma, J., & Zhang, R. (2022) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530322666220407090916 · Cited by 5
Ebrahimi, F., Urwyler, S. A., Schüetz, P., Müeller, B., Bernasconi, L., Neyer, P. J., Donath, M. Y., & Christ‐Crain, M. (2019) · Endocrine Connections · doi:10.1530/ec-19-0201 · Cited by 4
12/15-lipoxygenase deficiency attenuates disturbed flow-induced LDL oxidation in endothelial cells
Chen, J. W., Li, Y. R., Tao, L. Y., Tang, S. Y., Shu, X. Y., Feng, S., Yuan, R. S., Tay, G. P., Zhang, R., Yang, C. D., et al. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.153010 · Cited by 3
Self-citationPML Is Limiting NLRP3 Inflammasome Activity in Human Endothelial Cells
Liem, C. H., Steinemann, G., Ghiroltean, N., Yvonne, Y., Sakr, H., Nguyen, H., Baum, O., & Berkholz, J. (2025) · Cells · doi:10.3390/cells14241961 · Cited by 3
Moving with and beyond CANTOS: How to put out the fire of inflammation in atherosclerosis?
Cai, Z., Shen, L., & He, B. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.05.123 · Cited by 3
Abas, R., Basir, R., Thani, S. M., Salihan, S., Saat, A., Zainal, N. H. M., Asri, S. F. M., Razak, N. I. A., Nor, N. H. M., & Kamaruddin, N. A. (2022) · Malaysian Journal of Medical Sciences · doi:10.21315/mjms2022.29.2.2 · Cited by 3
The role of vascular aging, bone marrow and immune system in hypertension
Chen, Y., Yang, M., Xie, W., & Hong, H. (2026) · Cell Death Discovery · doi:10.1038/s41420-025-02851-9 · Cited by 2
SREBPs in Metabolic Reprogramming and Disease: Mechanisms and Therapeutic Potential
Zou, X., Li, Y., Yang, M., Liu, L., Wu, R., Cui, G., & Dai, J. (2026) · The FASEB Journal · doi:10.1096/fj.202600280rr · Cited by 3
Defining “Vulnerable” in coronary artery disease: predisposing factors and preventive measures
Adamopoulou, E., Dimitriadis, K. S., Kyriakoulis, K., Pyrpyris, N., Beneki, E., Fragkoulis, C., Konstantinidis, D., Aznaouridis, K. A., & Tsioufis, K. P. (2025) · Cardiovascular Pathology · doi:10.1016/j.carpath.2025.107736 · Cited by 2
Roles of Macrophage Mitochondrial Oxidative Stress and Mitochondrial Fission in Atherosclerosis
Wang, Y. (2014) · doi:10.7916/d84x55xn · Cited by 2
Jiang, R., Li, L., Luo, Y., Wang, W., Zeng, X., Cheng, Q., Gong, C., & Sheng, J. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116394 · Cited by 1
Self-citationFluoxetine disrupts cholesterol metabolism in endothelial cells via SREBP2 activation
Oliveira, F., Papa, C., Hagemann, T., Schipper, R., Florian, G., Roexe, T., Zulfqar, F., Prönnecke, C., Schmidt, L., Stryhanyuk, H., et al. (2026) · Translational Psychiatry · doi:10.1038/s41398-026-04197-x · Cited by 1
Wei, W., Yi, L., Pan, Y., Tan, J., Hao, Z., Zhang, L., Luo, X., Li, M., Xiao, Z., & Xin, W. (2026) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2026.08.008 · Cited by 1
A Revised Hemodynamic Theory of Age-Related
Gelfand, B. D., & Ambati, J. (2016)
彭, 晴. (2020) · Advances in Clinical Medicine · doi:10.12677/acm.2020.1010354
095T60103 幼児の自然体験活動を通した保育・教育実践II : 幼児キャンプ中の身体状況について(09.体育方法,一般研究発表)
三宅, 孝., 嶋崎, 博., 北尾, 岳., 足立, 正., & 服部, 伸. (2004) · 日本体育学会大会号
Sun, Z., Khan, A. H., & Tian, X. (2021) · Springer eBooks · doi:10.1007/978-3-030-22009-9_1069
Endothelial Shear Stress and Atherosclerosis: From Mechanisms to TherapeuticsPreprint
He, L., Zhang, C., Chen, Q., Wang, L., & Huang, Y. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3975295
Sun, Z., Khan, A. H., & Tian, X. (2019) · Springer eBooks · doi:10.1007/978-3-319-69892-2_1069-1
CORONARY ARTERY DISEASE INFLAMMATORY PATHWAYS AND INTERVENTIONS
Silvis, M. J. M. (2022) · doi:10.33540/954
Xu, Y., Wang, Q., Lu, Y. H., Shi, Q., Xu, L., Chen, S., You, Z., Han, M., & Zhang, Y. (2023) · Research Square · doi:10.21203/rs.3.rs-2935166/v1
Ridker, P. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-28786-9.00031-1
Mukai, R., Itagaki, K., Honjo, J., Tanaka, K., Norikawa, K., & Sekiryu, T. (2024) · Japanese Journal of Ophthalmology · doi:10.1007/s10384-024-01057-3
Sobrecarga de cobre y enfermedad de Alzheimer, búsqueda de posibles blancos terapéuticos
Zubillaga, M. (2023) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · doi:10.35537/10915/165188
Арманович, А. А., Kaktursky, L. V., Urazova, O. I., Трофименко, А. И., Sukiasyan, L. M., Коган, Е. А., Демура, Т. А., & Вачиковна, П. Н. (2025) · Bulletin of Siberian Medicine · doi:10.20538/1682-0363-2025-2-124-140 · Cited by 1
Pillay, R., Naidoo, P., & Mkhize‐Kwitshana, Z. L. (2025) · Pathogens · doi:10.3390/pathogens14080795
Xia, C., Fu, M., Tian, R., Ren, Y., Xu, X., Zhang, J., Xia, C., You, C., Hu, N., Lui, S., et al. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1665883
Guo, S., Xu, L., Chen, Y., Zhao, Y., Zhang, Y., Yu, R., Cao, K., Wang, L., Ai, W., Luo, J., et al. (2026) · Circulation · doi:10.1161/circulationaha.125.075951
Vatanparast, R. G., Ghoflchi, S., Aliyari, M., Mohammadi, H., Yazdi, M., & Hosseini, H. (2026) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2026.107065
Takizawa, R., Ichihara, G., Suzuki, Y., Izuoka, K., Hayashi, Y., Zong, C., Ikegami, A., & Ichihara, S. (2026) · Toxicology Letters · doi:10.1016/j.toxlet.2026.111891
Qin, M., Wang, L., Shan, D., Lin, D., Chen, Q., Yan, S., Liao, L., Luo, X., Zhang, Y., & Yu, J. (2026) · Talanta · doi:10.1016/j.talanta.2026.129840
SREBP1 Transactivation of NHE3 Impairs Cardiac Contraction and Aggravates Heart Failure
Gu, H., Wen, J., Liu, Y., Xue, Y., Zhao, M. H., Zhao, Y., Bi, L., Cui, H., Zhang, W., Xu, W., et al. (2026) · Circulation · doi:10.1161/circulationaha.126.079823
Self-citationCitrin, K. M., Huang, Y., Ramos-Perez, A., Castellanos, C., Canfrán‐Duque, A., Zhang, X., Chaube, B., de Urturi, D. S., Gómez‐Coronado, D., Libreros, S., et al. (2026) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2026.120800
Liang, Z., Xing, S., Chen, Y., Liu, M. D., Chang, S., Cai, Y., Xiong, Q., Xu, Y., & Liu, J. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1790475
Dhaou, C. B., Rom, O., & Orr, A. W. (2026) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2026.101624
Metadata
- Authors
- Xiao, H., Lu, M., Lin, T. Y., Chen, Z., Chen, G., Wang, W.-C., Marin, T., Shentu, T.-P., Wen, L., Gongol, B., Sun, W., Liang, X., Chen, J., Huang, H.-D., Pedra, J. H. F., Johnson, D. A., & Shyy, J. Y.-J.
- Affiliations
- University of California, Riverside (US)
- ORCID
- Venue
- Circulation
- Published
- 2013-08-06
- Volume
- 128
- Issue
- 6
- Pages
- 632-642
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- PMC
- PMC3798034
- OpenAlex
- W2022621797
- Cited by
- 257
- References
- 47
- Citations by year
- 2026: 14 · 2025: 15 · 2024: 14 · 2023: 15 · 2022: 22 · 2021: 32 · 2020: 18 · 2019: 23 · 2018: 15 · 2017: 19 · 2016: 25 · 2015: 17 · 2014: 25 · 2013: 2
- FWCI
- 12.71
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Natural Science Foundation of China (81270349)
- National Science Council (NSC 101-2311-B-009-003-MY3, NSC 100-2627-B-009-002, NSC 101-2911-I-009-101)
- National Institutes of Health
- University of California, San Diego
- National Heart, Lung, and Blood Institute (R01HL105318, R01HL089940, HL89940, HL105318)
- National Institute of Allergy and Infectious Diseases (R01AI093653)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- SREBP2, NLRP3 inflammasome, endothelial cells, oscillatory flow, flow disturbance, atherosclerosis, hemodynamics, NADPH oxidase 2, innate immunity, hyperlipidemia
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, NADPH Oxidase 2, Animals, Apolipoproteins E, Carrier Proteins, Hemodynamics, Humans, Immunity, Innate, Male, Membrane Glycoproteins, Mice, Transgenic, Stress, Mechanical, Vasculitis, NADPH Oxidases, RNA, Small Interfering, MicroRNAs, Endothelial Cells, Atherosclerosis, Mice, Sterol Regulatory Element Binding Protein 2, Inflammasomes, Human Umbilical Vein Endothelial Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
